vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $104.5M, roughly 1.4× Immunocore Holdings plc). On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 24.3%). Shoals Technologies Group, Inc. produced more free cash flow last quarter ($-11.3M vs $-35.5M). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

IMCR vs SHLS — Head-to-Head

Bigger by revenue
SHLS
SHLS
1.4× larger
SHLS
$148.3M
$104.5M
IMCR
Growing faster (revenue YoY)
SHLS
SHLS
+14.3% gap
SHLS
38.6%
24.3%
IMCR
More free cash flow
SHLS
SHLS
$24.3M more FCF
SHLS
$-11.3M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
SHLS
SHLS
Annualised
SHLS
27.8%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
SHLS
SHLS
Revenue
$104.5M
$148.3M
Net Profit
$8.1M
Gross Margin
97.4%
31.6%
Operating Margin
-18.8%
11.7%
Net Margin
5.5%
Revenue YoY
24.3%
38.6%
Net Profit YoY
3.9%
EPS (diluted)
$-0.61
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
SHLS
SHLS
Q4 25
$104.5M
$148.3M
Q3 25
$103.7M
$135.8M
Q2 25
$98.0M
$110.8M
Q1 25
$93.9M
$80.4M
Q4 24
$84.1M
$107.0M
Q3 24
$80.2M
$102.2M
Q2 24
$75.4M
$99.2M
Q1 24
$70.5M
$90.8M
Net Profit
IMCR
IMCR
SHLS
SHLS
Q4 25
$8.1M
Q3 25
$-177.0K
$11.9M
Q2 25
$-10.3M
$13.9M
Q1 25
$5.0M
$-282.0K
Q4 24
$7.8M
Q3 24
$8.7M
$-267.0K
Q2 24
$-11.6M
$11.8M
Q1 24
$-24.4M
$4.8M
Gross Margin
IMCR
IMCR
SHLS
SHLS
Q4 25
97.4%
31.6%
Q3 25
99.5%
37.0%
Q2 25
98.9%
37.2%
Q1 25
99.1%
35.0%
Q4 24
99.6%
37.6%
Q3 24
99.4%
24.8%
Q2 24
97.7%
40.3%
Q1 24
99.7%
40.2%
Operating Margin
IMCR
IMCR
SHLS
SHLS
Q4 25
-18.8%
11.7%
Q3 25
-6.9%
13.7%
Q2 25
-15.2%
14.4%
Q1 25
-3.9%
5.4%
Q4 24
-23.1%
15.4%
Q3 24
-10.6%
4.4%
Q2 24
-21.2%
18.7%
Q1 24
-37.6%
12.8%
Net Margin
IMCR
IMCR
SHLS
SHLS
Q4 25
5.5%
Q3 25
-0.2%
8.7%
Q2 25
-10.5%
12.5%
Q1 25
5.4%
-0.4%
Q4 24
7.3%
Q3 24
10.9%
-0.3%
Q2 24
-15.4%
11.9%
Q1 24
-34.7%
5.3%
EPS (diluted)
IMCR
IMCR
SHLS
SHLS
Q4 25
$-0.61
$0.05
Q3 25
$0.00
$0.07
Q2 25
$-0.20
$0.08
Q1 25
$0.10
$0.00
Q4 24
$-0.47
$0.04
Q3 24
$0.17
$0.00
Q2 24
$-0.23
$0.07
Q1 24
$-0.49
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$864.2M
$7.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$600.0M
Total Assets
$1.1B
$904.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
SHLS
SHLS
Q4 25
$864.2M
$7.3M
Q3 25
$892.4M
$8.6M
Q2 25
$882.8M
$4.7M
Q1 25
$837.0M
$35.6M
Q4 24
$820.4M
$23.5M
Q3 24
$901.3M
$11.1M
Q2 24
$859.6M
$3.2M
Q1 24
$832.8M
$15.2M
Total Debt
IMCR
IMCR
SHLS
SHLS
Q4 25
Q3 25
Q2 25
Q1 25
$141.8M
Q4 24
$141.8M
Q3 24
$438.7M
$141.8M
Q2 24
$452.5M
$146.8M
Q1 24
$452.5M
$168.8M
Stockholders' Equity
IMCR
IMCR
SHLS
SHLS
Q4 25
$381.0M
$600.0M
Q3 25
$396.6M
$589.6M
Q2 25
$388.5M
$575.4M
Q1 25
$378.5M
$558.9M
Q4 24
$360.7M
$556.8M
Q3 24
$377.8M
$545.2M
Q2 24
$359.1M
$544.6M
Q1 24
$359.5M
$554.0M
Total Assets
IMCR
IMCR
SHLS
SHLS
Q4 25
$1.1B
$904.1M
Q3 25
$1.1B
$851.8M
Q2 25
$1.1B
$795.0M
Q1 25
$1.0B
$788.4M
Q4 24
$1.0B
$793.1M
Q3 24
$1.1B
$801.3M
Q2 24
$1.0B
$788.4M
Q1 24
$994.0M
$825.3M
Debt / Equity
IMCR
IMCR
SHLS
SHLS
Q4 25
Q3 25
Q2 25
Q1 25
0.25×
Q4 24
0.25×
Q3 24
1.16×
0.26×
Q2 24
1.26×
0.27×
Q1 24
1.26×
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
SHLS
SHLS
Operating Cash FlowLast quarter
$-32.7M
$-4.1M
Free Cash FlowOCF − Capex
$-35.5M
$-11.3M
FCF MarginFCF / Revenue
-34.0%
-7.6%
Capex IntensityCapex / Revenue
2.8%
4.8%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
SHLS
SHLS
Q4 25
$-32.7M
$-4.1M
Q3 25
$-4.5M
$19.4M
Q2 25
$26.0M
$-13.8M
Q1 25
$435.0K
$15.6M
Q4 24
$-14.0M
$14.0M
Q3 24
$21.1M
$15.7M
Q2 24
$23.5M
$37.8M
Q1 24
$-4.6M
$12.9M
Free Cash Flow
IMCR
IMCR
SHLS
SHLS
Q4 25
$-35.5M
$-11.3M
Q3 25
$-5.2M
$9.0M
Q2 25
$25.6M
$-26.0M
Q1 25
$137.0K
$12.3M
Q4 24
$-17.5M
$12.5M
Q3 24
$20.3M
$13.3M
Q2 24
$23.1M
$35.8M
Q1 24
$-5.0M
$10.4M
FCF Margin
IMCR
IMCR
SHLS
SHLS
Q4 25
-34.0%
-7.6%
Q3 25
-5.0%
6.6%
Q2 25
26.1%
-23.5%
Q1 25
0.1%
15.4%
Q4 24
-20.9%
11.6%
Q3 24
25.3%
13.0%
Q2 24
30.7%
36.1%
Q1 24
-7.1%
11.4%
Capex Intensity
IMCR
IMCR
SHLS
SHLS
Q4 25
2.8%
4.8%
Q3 25
0.7%
7.7%
Q2 25
0.4%
11.0%
Q1 25
0.3%
4.0%
Q4 24
4.3%
1.4%
Q3 24
1.0%
2.3%
Q2 24
0.4%
2.0%
Q1 24
0.6%
2.7%
Cash Conversion
IMCR
IMCR
SHLS
SHLS
Q4 25
-0.50×
Q3 25
1.63×
Q2 25
-1.00×
Q1 25
0.09×
Q4 24
1.79×
Q3 24
2.42×
Q2 24
3.21×
Q1 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons